In Patients With ST-Segment Elevation Myocardial Infarction, Which Fibrinolytic Agent Is the Safest and Most Effective?
dc.contributor.author | Shrestha, Ashis | |
dc.contributor.author | House, Darlene R. | |
dc.contributor.author | Welch, Julie L. | |
dc.contributor.department | Emergency Medicine, School of Medicine | en_US |
dc.date.accessioned | 2018-03-28T16:50:32Z | |
dc.date.available | 2018-03-28T16:50:32Z | |
dc.date.issued | 2018 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Shrestha, A., House, D. R., & Welch, J. L. (2018). In Patients With ST-Segment Elevation Myocardial Infarction, Which Fibrinolytic Agent Is the Safest and Most Effective?. Annals of emergency medicine. https://doi.org/10.1016/j.annemergmed.2018.01.042 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/15728 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.annemergmed.2018.01.042 | en_US |
dc.relation.journal | Annals of Emergency Medicine | en_US |
dc.rights | IUPUI Open Access Policy | en_US |
dc.source | Author | en_US |
dc.subject | ST-segment elevation myocardial infarction | en_US |
dc.subject | fibrinolytic agents | en_US |
dc.subject | randomized controlled trial | en_US |
dc.title | In Patients With ST-Segment Elevation Myocardial Infarction, Which Fibrinolytic Agent Is the Safest and Most Effective? | en_US |
dc.type | Article | en_US |